Contact Us
Differential diagnosis Rapid results Preferred testing method Overuse of antibiotics

Is it influenza? Or another viral or bacterial infection?
Make a diagnosis, sooner, for better patient outcomes

For seasonal acute respiratory tract infections, timely clinical decision-making is crucial. Molecular respiratory syndromic panels from Quest Diagnostics provide accurate, rapid results for diagnosis of influenza A/B, respiratory syncytial virus (RSV), other viruses, or bacterial infection.

Make a differential diagnosis

Influenza, other viruses, and some bacterial infections can have similar symptoms, making a differential diagnosis challenging. Molecular panels from Quest can help.

  • Determine if symptoms are due to a viral or bacterial infection
  • Identify the pathogen for a more accurate diagnosis, to inform more effective treatment
  • Diagnose infections that may have been commonly missed, due to a lack of clinical suspicion or available routine testing1
 
Read more
Read less

Get rapid results

During an acute care visit, your patients want immediate relief and a quick return to daily activities. You want better outcomes sooner, too. Quest’s respiratory panels provide accurate, rapid results.

  • Benefit from rapid turnaround time (24–48 hours)
  • Shorten time to diagnosis compared to that of traditional culture methods1
  • Make informed decisions regarding infection control measures and timely outbreak investigations1
 
Read more
Read less

Use the preferred testing method

Evidence is increasing that molecular viral panel tests are preferable to traditional virus detection methods (eg, culture, rapid antigen detection test, direct fluorescent antibody).2

Molecular viral panels offer:2

  • Enhanced sensitivity and specificity
  • A broader range of virus detection
  • Rapid turnaround time
  • High positive predictive values, even during times of low viral prevalence
 
Read more
Read less

Avoid overuse of antibiotics

Quest’s panels help clinicians rapidly identify the pathogen causing a patient’s illness, allowing therapy to be tailored; this includes adding or discontinuing antibiotic therapy as indicated.

  • Know when it’s a virus and avoid overuse of antibiotics
  • Prescribe the most effective treatment, and help prevent prolonged illness
  • Support Centers for Disease Control and Prevention (CDC) recommendations to change the way antibiotics are used and combat a growing public health issue3
 
Read more
Read less

Benefit from expanded testing options

Whether you suspect a viral or bacterial infection, our respiratory testing panels can address your clinical needs. Quest’s new Respiratory Pathogen Panel expands our testing options to include bacterial pathogens in addition to viral, for the most accurate diagnosis.

Respiratory Virus Panel

Respiratory Pathogen Panel

Test Code

95512

37444

CPT Code*

87633

87633, 87486, 87581

Pathogens Detected

Adenovirus
Human Metapneumovirus
Influenza A
Influenza A H1
Influenza A H3
Influenza B
Parainfluenza 1,2,3
RSV-A
RSV-B
Rhinovirus

Adenovirus
Human Metapneumovirus
Influenza A
Influenza A H1
Influenza A H3
Influenza B
Parainfluenza virus 1,2,3,4
RSV-A
RSV-B
Rhinovirus/Enterovirus
Bocavirus
Coronavirus 229E
Coronavirus OC43
Coronavirus NL63
Coronavirus HKU1
Chlamydophila pneumoniae
Mycoplasma pneumoniae

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Rule a pathogen in or out with help from Quest.

Learn more about our respiratory virus and pathogen testing.

 

Download flyer

 

Read blog

 

Connect with us today, and a Quest sales representative will be in touch

References

  1. Ramanan P, Bryson AL, Binnicker MJ, et al. Syndromic panel-based testing in clinical microbiology. Clin Microbiol. 2018;31(1):e00024-17.
  2. Ginocchio G, McAdam A. Current best practices for respiratory virus testing. J Clin Microbiology. 2011:49(9);S44-S48.
  3. Centers for Disease Control and Prevention. About microbial resistance. September 10, 2018. www.cdc.gov/drugresistance/about.html. Accessed December 18, 2018.
Terms of Use  |  Privacy Notices  |  Contact Us  |  QuestDiagnostics.com  | Privacy Shield | Your Privacy Choices

Quest, Quest Diagnostics, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2022 Quest Diagnostics Incorporated. All rights reserved.